当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2013年
12期
133-134
,共2页
邓军%武兴杰%黄树圭%李军
鄧軍%武興傑%黃樹圭%李軍
산군%무흥걸%황수규%리군
海乐普%输卵管再通术%输卵管阻塞
海樂普%輸卵管再通術%輸卵管阻塞
해악보%수란관재통술%수란관조새
Derivatives of glucose acyl chitosan%Recanalization of tubal obstruction prevention recurrence of tubal obstruction%Salpingemphraxis
目的研究海乐普(壳聚糖衍生物酰氨基葡萄糖)预防输卵管介入再通术后再阻塞的临床疗效.方法选取112例输卵管阻塞性患者,随机分为研究组(34例)和治疗组(78例).研究组输卵管再通后行防阻塞液和海乐普灌注,治疗组再通后只单纯行防阻塞液灌注治疗.结果研究组阻塞输卵管再通率为96.8%(60/62),治疗组为97.4%(148/152);研究组术后12个月内妊娠率为35.3%(12/34),治疗组为16.7%(13/78),两组术后妊娠率比较,差异有统计学意义(P<0.05).结论防阻塞液加海乐普比单用防阻塞液更能有效预防输卵管再通术后再阻塞,值得临床推广应用.
目的研究海樂普(殼聚糖衍生物酰氨基葡萄糖)預防輸卵管介入再通術後再阻塞的臨床療效.方法選取112例輸卵管阻塞性患者,隨機分為研究組(34例)和治療組(78例).研究組輸卵管再通後行防阻塞液和海樂普灌註,治療組再通後隻單純行防阻塞液灌註治療.結果研究組阻塞輸卵管再通率為96.8%(60/62),治療組為97.4%(148/152);研究組術後12箇月內妊娠率為35.3%(12/34),治療組為16.7%(13/78),兩組術後妊娠率比較,差異有統計學意義(P<0.05).結論防阻塞液加海樂普比單用防阻塞液更能有效預防輸卵管再通術後再阻塞,值得臨床推廣應用.
목적연구해악보(각취당연생물선안기포도당)예방수란관개입재통술후재조새적림상료효.방법선취112례수란관조새성환자,수궤분위연구조(34례)화치료조(78례).연구조수란관재통후행방조새액화해악보관주,치료조재통후지단순행방조새액관주치료.결과연구조조새수란관재통솔위96.8%(60/62),치료조위97.4%(148/152);연구조술후12개월내임신솔위35.3%(12/34),치료조위16.7%(13/78),량조술후임신솔비교,차이유통계학의의(P<0.05).결론방조새액가해악보비단용방조새액경능유효예방수란관재통술후재조새,치득림상추엄응용.
@@@@Objective To investigate the efficacy of derivatives of glucose acyl chitosan to prevent tubal obstruction after recanalization surgery.Methods 112 patients with tubal obstruction were divided into two groups randomLy.The research group(n=34) was injected with injection of prentvention restenosis and derivatives of glucose acyl chitosan,and the comparion group(n=78)with injection of prentvention restenosis only.Results The recanalization rates of two groups were 96.8%(60/62) and 97.4%(148/152).The pregnancy rate in the research group was 35.3%(12/34),and the comparion group was 16.7%(13/78) in the following 12 months after recanalization surgery.There is a significant difference between the two groups(P<0.01).Conclusion Comparied with injection of prentvention restenosis only,derivatives of glucose acyl chitosan and injection of prentvention restenosis are more effective to prevent the recurrence of tubal obstruction after interventional recanalization surgery.